Experience with prophylaxis in Sweden.
Nilsson
I M
IM
Department for Coagulation Disorders, University of Lund, Malmö General Hospital, Sweden.
D000293:Adolescent; D002648:Child; D002675:Child, Preschool; D005164:Factor IX / Q000008:administration & dosage / Q000627:therapeutic use; D005169:Factor VIII / Q000008:administration & dosage / Q000627:therapeutic use; D006467:Hemophilia A / Q000150:complications / Q000188:drug therapy*; D006470:Hemorrhage / Q000209:etiology / Q000517:prevention & control; D006801:Humans; D007223:Infant; D007592:Joint Diseases / Q000209:etiology / Q000517:prevention & control*; D008297:Male; D013548:Sweden
D005169:Factor VIII; D005164:Factor IX